Many of these proteins (FABP7, FASN and ELOVL2) are up-regulated in GBM patient-derived tumor stem cell cultures compared to more-differentiated adherent cells cultured in serum-containing medium [13,19,40]. This evidence concerns the gene ELOVL2 and neoplasm.